Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus

被引:2
|
作者
Song, Do Kyeong [1 ]
Hong, Young Sun [1 ]
Sung, Yeon-Ah [1 ]
Lee, Hyejin [1 ]
机构
[1] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea
来源
PLOS ONE | 2024年 / 19卷 / 02期
关键词
CAUSE-SPECIFIC MORTALITY; MULTIFACTORIAL INTERVENTION; BLOOD-PRESSURE; DISEASE; OUTCOMES;
D O I
10.1371/journal.pone.0299035
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Since patients with type 2 diabetes mellitus (T2DM) have an increased risk of cardiovascular events, interventions addressing risk factors reduce the incidence of cardiovascular disease (CVD) events. This study aimed to evaluate the difference in the incidence of CVD events according to risk factor control in patients with diabetes with and without cardio-renal disease.Methods We analyzed 113,909 patients with diabetes and 290,339 without diabetes using data released by the National Health Insurance Service (NHIS).Results Among patients with diabetes with four or five poorly controlled risk factors, hazard ratio for CVD events was 1.19 (95% confidence interval [CI], 1.06-1.34) in patients with cardio-renal disease and 2.31 (95% CI, 1.95-2.74) in patients without cardio-renal disease compared to patients with diabetes without risk factors. In subjects with diabetes and cardio-renal disease, patients with four or five poorly controlled risk factors had a higher risk of CVD mortality compared to subjects without risk factors (hazard ratio, 1.64; 95% CI, 1.18-2.30).Conclusion Controlling cardiovascular risk factors reduced the incidence of CVD events in patients with diabetes, especially those without cardio-renal disease. The degree of risk control was strongly associated with CVD mortality in patients with diabetes with baseline cardio-renal disease.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Evaluation of Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
    Reingold, Jason S.
    Nasir, Khurram
    Patel, Neel R.
    Pourfarzib, Ray
    Winegar, Deborah
    DIABETES, 2013, 62 : A614 - A615
  • [22] Prevention of cardiovascular risk in patients with type 2 diabetes mellitus with aspirin
    Duly-Bouhanick, B
    Menard, S
    Hadjadj, S
    Soares-Barbosa, S
    Plun-Favreau, J
    Guilloteau, G
    PRESSE MEDICALE, 2001, 30 (02): : 87 - 91
  • [23] Predictor for cardiovascular risk in patients with type-2 diabetes mellitus
    Azharuddin, Md
    Kapur, Prem
    Mishra, Ritu
    Saleem, Shakir
    Gupta, Ashok Kumar
    Adil, Mohammad
    Sharma, Manju
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 12
  • [24] Risk Factors and cardiovascular Outcomes in Patients with type 2 Diabetes Mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2018, 14 (07): : 499 - 500
  • [25] 4.25 EKG Left Ventricular Hypertrophy and Risk of Cardiovascular Events in Patients with Type 1 and Type 2 Diabetes Mellitus
    M. Salvetti
    M. L. Muiesan
    B. Stanga
    A. Cimino
    U. Valentini
    A. Paini
    E. Belotti
    L. Micheletti
    C. Aggiusti
    C. Agabiti Rosei
    V. Paderno
    E. Agabiti Rosei
    High Blood Pressure & Cardiovascular Prevention, 2007, 14 (3) : 145 - 145
  • [26] Osteprotegerin as cardiovascular risk marker in patients with type 2 diabetes mellitus
    Rozas-Moreno, P.
    Munoz-Torres, M.
    Alonso, G.
    Fernandez-Garcia, D.
    Luque-Fernandez, I.
    Sebastian-Ochoa, A.
    Escobar-Jimenez, F.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S271 - S271
  • [27] Reducing Global Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
    Gavin, James R., III
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2008, 108 (05): : S14 - S19
  • [28] Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus
    Zeng, De-kang
    Xiao, Qian
    Li, Fa-qi
    Tang, Yu-zhi
    Jia, Chao-li
    Tang, Xue-wen
    BIOSCIENCE REPORTS, 2019, 39
  • [29] Assessment of Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus
    Ramona, Dragut R.
    Rusu, Emilia
    Radulian, Gabriela
    Parpala, Cristina
    Popescu, Horatiu
    Nan, Raluca
    DIABETES, 2012, 61 : A562 - A563
  • [30] EFFECTS OF INTENSIVE BLOOD PRESSURE CONTROL ON CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES MELLITUS: THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) BLOOD PRESSURE TRIAL
    Grimm, R.
    JOURNAL OF HYPERTENSION, 2010, 28 : E602 - E602